Asia / HONG KONG
To continue to view the full report
Buy this company's report, or subscribe to a plan.
Company Overview
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacturing, and sale of pharmaceutical products. It operates through the Proprietary and Generic Products and Licensed-in Products segments. The Proprietary and Generic Products segment is involved in the manufacturing and sales of self-developed and generic pharmaceutical products. The Licensed-in Products segment focuses on the trading of licensed-in pharmaceutical products. The company was founded by Xiao Yi Li in 1994 and is headquartered in Hong Kong.
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacturing, and sale of pharmaceutical products. It operates through the Proprietary and Generic Products and Licensed-in Products segments. The Proprietary and Generic Products segment is involved in the manufacturing and sales of self-developed and generic pharmaceutical products. The Licensed-in Products segment focuses on the trading of licensed-in pharmaceutical products. The company was founded by Xiao Yi Li in 1994 and is headquartered in Hong Kong.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Pharmaceutical Preparations |
| Country | HONG KONG |
| Employees | 1,094 |
| Reporting Unit | Millions |
| Primary Exchange | FRA HKG BLN |
| Instrument Type | Equity |
| Website | http://www.leespharm.com |
| Wright ID | C344MJB2T |
Key Metrics
| Current price | $1.07 |
| Market cap | $627.1 M |
| P/E ratio | 5.24 |
| 52-week perf. | -41.4% |
| Common shares | 588.8 M |
| Closely held | 268.6 M |
| Share type | Ordinary |
| Quality rating | LBD0 |
| Dividend yield | 4.41% |
Recent stock performance
| 1 Week | +3.4% |
| 4 Week | -9.0% |
| 13 Week | +2.5% |
Officers
| Executive Chairman | Siu Fong Lee |
| Chief Financial Officer & Secretary | Yiu Ming Chow |
Address
No2 Science Park West Avenue
HONG KONG
| Phone | n/a |
Quarterly Earnings & Dividends
Try another report for annual statements, Wright Quality history or comparative analysis.